Objective psychological measurement and clinical assessment of anxiety in adverse drug reactions

Canadian Journal of Clinical Pharmacology

Volumn 11, Issue 1, 2004, Pages

  Ong, Debra ^a   Popat, Alpa ^a   Knowles, Sandra R ^b   Arrowood, John S ^c   Shear, Neil H ^a,b,d   Binkley, Karen E ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adverse drug reaction; Anxiety; Idiopathic environmental intolerance; Psychogenic reactions; Trauma symptom checklist 40

Indexed keywords

ACETYLSALICYLIC ACID; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID DERIVATIVE; LOCAL ANESTHETIC AGENT; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; DRUG;

ADULT; AGED; ANXIETY; ARTICLE; CHECKLIST; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISSOCIATIVE DISORDER; DRUG INDUCED DISEASE; FEMALE; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL ABUSE; SEXUAL DYSFUNCTION; SLEEP DISORDER; UNSPECIFIED SIDE EFFECT; ADOLESCENT; COMPARATIVE STUDY; MIDDLE AGED; NONPARAMETRIC TEST; PHYSICIAN ATTITUDE; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; STANDARD; STATISTICS; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; ANXIETY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S ROLE; PSYCHOLOGICAL TESTS; STATISTICS, NONPARAMETRIC;

EID: 18944397221     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Karch F, Lasagna L. Adverse drug reactions. JAMA 1975;234:1236-41.
2. Miller R. Drug surveillance utilizing epidemiologic methods. A report form the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm 1973;30:584-92.
3. Lakshmanan M, Hershey C, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med 1986;146:1931-4.
4. Edwards I, Aronson J. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000;356:1255-9.
5. Haber J, Knowles S, Knight A. Allergy to local anaesthetics. Allergy Asthma 2000;12:27-34.
6. Fiset L, Milgrom P, Weinstein P, Getz T, Glassman P. Psychophysiological responses to dental injections. J Am Dent Assoc 1985;111:578-83.
7. Staudenmayer H. Environmental illness: myth and reality. Boca Raton: Lewis Publishers; 1999.
8. American Academy of Allergy Asthma and Immunology. Idiopathic, enironmental intolerances (position statement). J Allergy Clin Immunol 1999;103:36-40.
9. Sparks P. Idiopathic environmental intolerances: overview. In: Sparks P, editor. Multiple Chemical Sensitivity/Idiopathic Environmental Intolerance. Philadelphia: Hanley & Belfus; 2000. p. 497-510.
10. Binkley K, King N, Poonai N, Seeman P, Ulpian C, Kennedy J. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele seven. J Allergy Clin Immunol 2001;107:887-90.
11. Giardino N, Lehrer P. Behavioral conditioning and idiopathic environmental intolerance. In: Sparks P, editor. Multiple Chemical Sensitivity/Idiopathic Environmental Intolerance. Philadelphia: Hanley & Belfus; 2000. p. 519-28.
12. Leznoff A, Binkley K. Idiopathic environmental intolerances: results of challenge studies. In: Sparks P, editor. Multiple Chemical Sensitivity/ Idiopathic Environmental Intolerance. Philadelphia: Hanley & Belfus; 2000. p. 529-37.
13. Dalton P, Hummel T. Chemosensor function and response in idiopathic environmental intolerance. In: Sparks P, editor. Multiple Chemical Sensitivity/Idiopathic ENvironmental Intolerance. Philadelphia: Hanley & Belfus; 2000. p. 539-56.
14. Black D. The relationship of mental disorders and idiopathic environmental intolerance. In: Sparks P, editor. Multiple Chemical Sensitivity/Idiopathic environmental Intolerance. Philadelphia: Hanley & Belfus; 2000. p. 557-70.
15. Staudenmayer H. Psychological treatmnet of psychogenic idiopathic environmental intolerance. In: Sparks P, editor. Multiple Chemical Sensitivity/Idiopathic Environmental Intolerance. Philadelphia: Hanley & Belfus; 2000. p. 627-46.
16. Poonai N, Antony M, Binkley K, et al. Carbon dioxide inhalation challenges in idiopathic environmental intolerance. J Allergy Clin Immunol 2000;105:358-63.
17. Leznoff A. Provocative challenges in patients with multiple chemical sensitivity. J Allergy Clin Immunol 1997;99:438-42.
18. Binkley K, Kutcher S. Panic response to sodium lactate infusion in patients with multiple chemical sensitivity syndrome. J Allergy Clin Immunol 1997;99:570-4.
19. Staudenmayer H, Camazine M. Sensing type personality, projection and universal allergic reactivity. J Psychol Type 1989;18:59-62.
20. Black D, Rathe A, Goldstein R. Environmental illness: a controlled study of 26 subjects with "20th century disease". JAMA 1990;264:3166-70.
21. Rosenberg S, Freedman M, Schmaling K, Rose C. Personality styles of patients asserting environmental illness. J Occup Med 1990;32:678-81.
22. Selner J, Staudenmayer H. Neuropsychophysiologic observations in patients presenting with environmental illness. Toxicol In Health 1992;8:145-55.
23. Staudenmayer H, Selner M, Selner J. Adult sequelae of childhood abuse presenting as environmental illness. Ann Allergy 1993;711:538-46.
24. Briere J, Runtz M. The trauma symptom checklist (TSC-33): early data on a new scale. J Interpersonal Violence 1989;4:151-63.
25. Elliott D, Briere J. Sexual abuse trauma among professional women: validating the Trauma Symptom Checklist-40 (TSC-40). Child Abuse Negl 1992;16:391-8.
26. Gold S, Milan L, Mayall A, Johnson A. A cross-validation study of the Trauma Symptom Checklist: the role of mediating variables. J Interpersonal Violence 1994;9:12-16.
27. Zlotnick C, Shear M, Begin A, Pearlstein T, SImpson E, Costello E. The validation of the Trauma Symtpom Checklist-40 (TSC-40) in a sample of inpatinets. Child Abuse Negl 1996;20:503-10.
28. Whiffen V, Benazon N, Bradshaw C. Discriminant validity of the TSC-40 in an outpatient setting. Child Abuse Negl 1997;21:107-15.
29. Gold J, Cardena E. Convergent validity of three posttraumatic symptoms inventories among adult sexual abuse survivors. J Trauma Stress 1998;11:173-80.
30. Briere J. Psychometric review of the Trauma Symptom Checklist-40. In: Stamm B, editor. Measurement of stress, trauma, and adaptation. Lutherville: Sidran Press; 1996.
31. Naranjo C, U, Sellers E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
32. Kreutzer R, Neutra R, Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol 1999;150:1-12.
33. Tran C, Knowles S, Liu B, NH. Gender differences in adverse drug reactions. J Clin Pharmacol 1998;38:1003-9.